KOLON LIFE SCIENCE Inc.
Founded in 2000 and listed on the KOSDAQ in 2009, Kolon Life Science is a raw pharmaceutical materials and bio-CDMO company that developed the cell and gene therapy Invossa-K.
Price
Change
Market cap
Products & technology
- Invossa-KCell and gene therapy for osteoarthritis
- APIs and pharmaceutical intermediatesRaw materials for new and generic synthetic drugs
- Antimicrobial agentsFunctional material inhibiting bacterial growth
- Biopharmaceutical CDMOContract development/manufacturing and technology licensing for biopharmaceuticals
Clinical trials
data.go.kr3 MFDS clinical trial authorisations · 2012–2017 (Phase 3 2 · Phase 2 1)
- Phase 3인보사케이주2017-11-22
16 trial sites
- Phase 3인보사케이주2013-08-06
12 trial sites
- Phase 2인보사케이주2012-04-02
6 trial sites
R&D and key agreements
Source: DART corporate disclosure인보사케이주 · 골관절염 · The world's first cell and gene therapy for osteoarthritis, led by research institute director Dr. Kim Su-jeong.
신경병증성 통증 치료제 · 신경병증성 통증 · One of Kolon Life Science's biopharmaceutical pipeline programs.
종양살상바이러스 · 암 · One of Kolon Life Science's biopharmaceutical pipeline programs (oncolytic virus).
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition